casetext.com/case/united-states-ex-rel-gohil-v-sanofi-aventis-us-inc-1

Mar 30, 2015 ... SANOFI–AVENTIS U.S. INC., et. al., Defendant. Carl D. Poplar, Cherry Hill, .... U.S. ex rel. Zizic v. Q2Administrators, LLC, 728 F.3d 228, 232 n.

www.rxinjuryhelp.com/wp-content/uploads/sanofi-taxotere-mdl-response.pdf?x19593

Aug 16, 2016 ... RESPONSE OF DEFENDANT SANOFI-AVENTIS U.S. LLC TO MOTION FOR ... At present, there are 48 federal actions pending in 22 separate ... Movants suggest that the Panel transfer all Taxotere ... (E.D.N.C. filed July 28, 2016); Medici v. ... Like the MDL petitions recently filed in In re: Johnson & Johnson.

www.winthropus.com

Winthrop US makes it possible for patients to receive high-quality Sanofi generic ... The same quality, reliability and commitment you've come to expect from Sanofi are now available from Winthrop US authorized generics. ... See all of our products ... Winthrop US, a business of Sanofi US © 2018 sanofi-aventis U.S. LLC. All ...

www.winthropus.com/about-authorized-generics

See how Winthrop US authorized generic prescription medications compare to their Sanofi brand name equalivents, in terms of active ingredients, ...

www.laed.uscourts.gov/sites/default/files/taxotere/Taxotere.MDL_.2740.Joint_.Report.No_.9.Liaison.Counsel.4-26-18.pdf

May 4, 2018 ... cases pending in the MDL before the Honorable Kurt D. Engelhardt. 2. ... A listing of all Pretrial Orders is attached to this Joint Report as ... B.9. The Court has issued the following Case Management Orders ..... Defendant Sanofi-Aventis U.S. LLC filed a Motion for Leave to file ...... Johnson, Reginald Ann v.

www.sec.gov/Archives/edgar/data/1121404/000119312511050947/d20f.htm

All references herein to “United States” or “U.S.” are to the United States of America, ... of Johnson & Johnson on certain geographical areas (except the United States where ... Information on the Company — B. Business Overview — Markets ...... sanofi-aventis recognises 100% of the Merial income on a separate line of the ...

www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/our-responsibility/Annual_Report_on_Form_20-F_2017.pdf?la=en&hash=65E62A5A37158ADC35D3D0B7A15318D320C6EC98

Dec 31, 2017 ... reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. YES ☐ NO ... All references herein to “United States” or “US” are to the ... Biomarin/Genzyme LLC; Avilomics®, a trademark of Avila ... Information on the Company – B. Business Overview – ...... Sanofi-Aventis Deutschland GmbH.

www.law.com/newyorklawjournal/2019/02/21/thursday-newspaper-389-7242/?download=NYLJthursdayB.pdf

Feb 21, 2019 ... LLC v. European Home Design LLC,. 17-CV-6238 (March 13). U.S. - SDNY ... Defendant, various separately-run .... The government satisfied §983(a)(3)(B)(ii)( II) by indicting Stege- .... Santana v Johnson, supra; Guerra v .... qualify for immunity under CPLR 3102[d] ...... WINTHROP ...... Sanofi-Aventis et al.

www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/publications/38473_Sanofi_20-F_2014.pdf

Dec 31, 2018 ... ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES .... the Joint Venture Biomarin/Genzyme LLC; Avilomics a trademark of Avila ... of Johnson & Johnson (except in the United States where it is a ...... S.A., Sanofi Chimie, Sanofi Winthrop Industrie, Sanofi, and Sanofi-Aventis.